Gail Garland

Founder & CEO, Ontario Bioscience Innovation Organization (OBIO®)

gail-6329Gail founded OBIO in 2009 following twenty years of experience including senior roles the banking, pharma, biotech and medical devices industries. The Ontario Bioscience Innovation Organization (OBIO) is a not-for-profit, membership-based organization engaged in the development of an integrated health innovation economy for Ontario and one that will become a global leader in providing health technology products and services to the international marketplace. OBIO advances this goal through advocacy, promotion and strategic leadership and via collaborative partnerships with industry, academia, patients and government. OBIO developed and implemented OBEST (Ontario Bioscience Economic Strategy Team) a province-wide strategic vision to support the growth and viability of Ontario’s bioscience industry. OBIO is an Ontario node of Natural Products Canada.

Under Gail’s leadership, OBIO leads several multi-stakeholder, cross-disciplinary collaborative initiatives to advance industry’s cause. In 2013, OBIO launched CAAP®, the ‘Capital Access Advisory Program’ to increase deal flow for high potential early stage companies. In 2015, OBIO launched Pre-CAAP to help boost investability of post seed stage companies, as well as, prepare companies for OBIO’s CAAP program. The OBIO CAAP program receives funding from both the Ontario Provincial and Federal (Federal Economic Development Agency) governments.

Gail serves on the Board of the Medical Device Commercialization Centre, a Centre of Excellence for Commercialization and Research. She serves on the Dean’s Advisory Council, Faculty of Science, Ryerson University; the Biotechnology Advisory Committee at Humber College and the Canadian Life Sciences Advisory Counsel for Springboard Enterprises. Gail is the Industry Chair of the OBIO MPP Health Sciences Caucus and is past Chair of the Advisory Board Advanced Health Technologies at the Ontario Centers of Excellence. She serves on, the Council for Innovation Procurement in Healthcare (Conference Board of Canada) and on the Editorial Board of Biotechnology Focus. She has advocated for the future of the health science industry on national television and has written extensively on the topic with numerous publications in the national press and international and industry publications.

Gail holds a Chartered Director (CDir) designation in governance (McMaster); an MBA from the Rotman School of Management, University of Toronto and a BSc. (Carleton University)